Compare GDEN & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDEN | PRME |
|---|---|---|
| Founded | N/A | 2019 |
| Country | United States | United States |
| Employees | 504 | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 763.2M | 666.1M |
| IPO Year | 1998 | 2022 |
| Metric | GDEN | PRME |
|---|---|---|
| Price | $27.69 | $3.71 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $32.25 | $7.56 |
| AVG Volume (30 Days) | 139.4K | ★ 2.6M |
| Earning Date | 06-01-2026 | 06-01-2026 |
| Dividend Yield | ★ 3.62% | N/A |
| EPS Growth | N/A | ★ 18.18 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $634,911,000.00 | $4,632,000.00 |
| Revenue This Year | $5.70 | $15.20 |
| Revenue Next Year | $2.96 | $316.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 55.28 |
| 52 Week Low | $19.57 | $1.11 |
| 52 Week High | $32.74 | $6.94 |
| Indicator | GDEN | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 39.60 | 46.17 |
| Support Level | $26.82 | $3.19 |
| Resistance Level | $27.95 | $4.66 |
| Average True Range (ATR) | 0.61 | 0.32 |
| MACD | -0.20 | -0.02 |
| Stochastic Oscillator | 21.82 | 34.71 |
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.